Bempedoic acid after heart attack: does it help?
Part of Heart & circulation clinical trials.
This trial tests whether bempedoic acid, a cholesterol-lowering drug, improves outcomes and reduces inflammation in people who have had a severe heart attack treated with emergency angioplasty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a type of heart attack called STEMI.
- You are scheduled to have emergency angioplasty (primary PCI) to open a blocked artery.
- You are not allergic to bempedoic acid.
- You do not have an active infection or a long-term inflammatory disease.
- You do not have severe liver or kidney problems.
- You are not currently taking medications that suppress your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests adding a newer cholesterol-lowering pill (bempedoic acid) to usual care for people who have been recently hospitalized for a heart event. It aims to see if the combination helps lower cholesterol better than standard medicines alone.
This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.
This study is checking how well people stick with taking bempedoic acid, a cholesterol-lowering medication, and how effective it is over time.
This study tests whether a stronger-than-usual cholesterol-lowering treatment right after a heart attack (STEMI or NSTEMI) can improve outcomes. It may help protect the heart by lowering harmful cholesterol quickly.
Hear when a new ST Elevation (STEMI) Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.